Thiazide-like Diuretic [EPC]

Thiazide-like Diuretic [EPC] was reported 43140 times

Drugs of the Thiazide-like Diuretic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONJOINED TWINS 35 0.3535
1 CENTRAL NERVOUS SYSTEM LUPUS 68 0.3049
2 HYPONATRAEMIC SEIZURE 30 0.1181
3 BUTTERFLY RASH 66 0.0651
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 65 0.0612
5 SENSITISATION 44 0.0580
6 NEPHROGENIC ANAEMIA 253 0.0546
7 HYPERPARATHYROIDISM SECONDARY 129 0.0514
8 RENAL ARTERY STENOSIS 70 0.0508
9 HYPOCHLORAEMIA 53 0.0452
10 METABOLIC ALKALOSIS 71 0.0442
11 RECTAL POLYP 41 0.0415
12 LUPUS NEPHRITIS 75 0.0401
13 HYPONATRAEMIA 1910 0.0339
14 CAROTID ARTERIOSCLEROSIS 34 0.0329
15 LEFT ATRIAL DILATATION 41 0.0321
16 REBOUND ACID HYPERSECRETION 91 0.0301
17 BLOOD PRESSURE SYSTOLIC ABNORMAL 74 0.0299
18 HYPOKALAEMIA 1362 0.0295
19 TACHYARRHYTHMIA 71 0.0284
20 ORTHOPNOEA 89 0.0279
21 HYPERVOLAEMIA 125 0.0253
22 END STAGE RENAL DISEASE 452 0.0248
23 BLOOD ELECTROLYTES ABNORMAL 30 0.0243
24 OBSTRUCTIVE SLEEP APNOEA SYNDROME 35 0.0240
25 RIGHT VENTRICULAR FAILURE 162 0.0231
26 HYPOVOLAEMIA 134 0.0229
27 CHANGE OF BOWEL HABIT 47 0.0229
28 PROTEIN URINE PRESENT 111 0.0222
29 HYPOMAGNESAEMIA 302 0.0217
30 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 222 0.0216
31 MUCOSAL DRYNESS 43 0.0213
32 BLOOD CHLORIDE DECREASED 55 0.0213
33 DIASTOLIC DYSFUNCTION 63 0.0204
34 LEFT VENTRICULAR HYPERTROPHY 85 0.0198
35 BRAIN NATRIURETIC PEPTIDE INCREASED 59 0.0191
36 DYSLIPIDAEMIA 96 0.0189
37 AORTIC ARTERIOSCLEROSIS 47 0.0182
38 BREATH SOUNDS ABNORMAL 89 0.0180
39 ISCHAEMIC CARDIOMYOPATHY 51 0.0166
40 FLUID OVERLOAD 242 0.0166
41 THERAPEUTIC AGENT TOXICITY 55 0.0165
42 TORSADE DE POINTES 126 0.0160
43 HYPOVOLAEMIC SHOCK 76 0.0158
44 BLOOD POTASSIUM DECREASED 477 0.0158
45 DEVICE INFUSION ISSUE 39 0.0157
46 GLOMERULAR FILTRATION RATE DECREASED 192 0.0156
47 NEPHROPATHY 145 0.0155
48 CHRONIC KIDNEY DISEASE 1179 0.0155
49 CARDIAC FAILURE ACUTE 103 0.0154
50 POTENTIATING DRUG INTERACTION 51 0.0152
51 POLYURIA 124 0.0151
52 SUPRAVENTRICULAR EXTRASYSTOLES 51 0.0151
53 AZOTAEMIA 60 0.0150
54 RETROPERITONEAL HAEMATOMA 33 0.0149
55 ACUTE KIDNEY INJURY 2271 0.0148
56 PULMONARY ARTERIAL HYPERTENSION 215 0.0148
57 PNEUMONIA VIRAL 47 0.0147
58 RALES 85 0.0146
59 BLOOD UREA INCREASED 245 0.0146
60 URINE ABNORMALITY 66 0.0145
61 HAEMATOCRIT INCREASED 33 0.0145
62 BUNDLE BRANCH BLOCK RIGHT 66 0.0144
63 BLOOD SODIUM DECREASED 271 0.0144
64 GOUT 255 0.0142
65 CARDIAC MURMUR 122 0.0141
66 RENAL MASS 29 0.0141
67 HYPERKALAEMIA 490 0.0140
68 BLOOD PRESSURE INADEQUATELY CONTROLLED 83 0.0138
69 ELECTROLYTE IMBALANCE 160 0.0138
70 CHRONIC GASTRITIS 31 0.0137
71 LOSS OF EMPLOYMENT 41 0.0136
72 CAROTID ARTERY STENOSIS 47 0.0134
73 HAEMORRHAGIC ANAEMIA 59 0.0134
74 HAEMOGLOBIN INCREASED 61 0.0134
75 AORTIC STENOSIS 46 0.0132
76 CREPITATIONS 39 0.0131
77 TRICUSPID VALVE INCOMPETENCE 104 0.0131
78 EUGLYCAEMIC DIABETIC KETOACIDOSIS 54 0.0131
79 INFUSION SITE HAEMORRHAGE 43 0.0131
80 BLOOD LOSS ANAEMIA 29 0.0128
81 LEFT VENTRICULAR FAILURE 44 0.0128
82 RENAL FAILURE CHRONIC 98 0.0127
83 CARDIAC FAILURE CHRONIC 54 0.0127
84 PULMONARY HYPERTENSION 262 0.0126
85 ARTERIOSCLEROSIS CORONARY ARTERY 82 0.0124
86 ARTERIOSCLEROSIS 116 0.0123
87 BUNDLE BRANCH BLOCK LEFT 52 0.0122
88 OXYGEN CONSUMPTION INCREASED 29 0.0121
89 ORTHOSTATIC HYPOTENSION 211 0.0121
90 FLUID RETENTION 615 0.0121
91 URINE ODOUR ABNORMAL 71 0.0121
92 SPINAL OSTEOARTHRITIS 106 0.0121
93 URINE OUTPUT DECREASED 105 0.0120
94 BLOOD PRESSURE SYSTOLIC INCREASED 234 0.0120
95 RENAL FAILURE ACUTE 506 0.0119
96 BLOOD POTASSIUM INCREASED 191 0.0118
97 DYSPNOEA AT REST 34 0.0117
98 OLIGURIA 70 0.0113
99 BLOOD POTASSIUM ABNORMAL 30 0.0112
100 CHRONIC SINUSITIS 42 0.0112
101 HYPERLACTACIDAEMIA 30 0.0112
102 POLYP 71 0.0108
103 CARDIAC FAILURE CONGESTIVE 870 0.0108
104 PRESYNCOPE 263 0.0108
105 DYSPNOEA EXERTIONAL 402 0.0107
106 INFUSION SITE PAIN 137 0.0106
107 POLYDIPSIA 42 0.0106
108 INFUSION SITE ERYTHEMA 89 0.0105
109 MITRAL VALVE INCOMPETENCE 119 0.0105
110 BLOOD CREATININE INCREASED 685 0.0105
111 MENINGITIS ASEPTIC 47 0.0105
112 TUBULOINTERSTITIAL NEPHRITIS 195 0.0104
113 BLOOD PRESSURE SYSTOLIC DECREASED 47 0.0103
114 PARANASAL SINUS DISCOMFORT 39 0.0103
115 VENTRICULAR HYPOKINESIA 33 0.0103
116 SINUS BRADYCARDIA 99 0.0102
117 ATELECTASIS 98 0.0101
118 BLOOD MAGNESIUM DECREASED 87 0.0101
119 RENAL FAILURE 1337 0.0101
120 INFUSION SITE SWELLING 63 0.0100
121 COVID-19 PNEUMONIA 118 0.0100
122 HIGH DENSITY LIPOPROTEIN DECREASED 33 0.0099
123 PERIPHERAL VASCULAR DISORDER 51 0.0099
124 OBESITY 157 0.0098
125 VENTRICULAR TACHYCARDIA 162 0.0098
126 DIZZINESS POSTURAL 95 0.0098
127 GENERALISED OEDEMA 121 0.0098
128 METABOLIC ENCEPHALOPATHY 29 0.0097
129 OEDEMA PERIPHERAL 1173 0.0096
130 ATRIOVENTRICULAR BLOCK SECOND DEGREE 29 0.0095
131 BLOOD URIC ACID INCREASED 55 0.0095
132 HYPOVENTILATION 31 0.0095
133 ATRIOVENTRICULAR BLOCK 73 0.0094
134 IRON DEFICIENCY ANAEMIA 87 0.0094
135 BRADYCARDIA 496 0.0093
136 IRON DEFICIENCY 42 0.0093
137 PROCTALGIA 60 0.0093
138 ATRIAL FIBRILLATION 908 0.0093
139 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 38 0.0093
140 TRIGGER FINGER 38 0.0093
141 ACUTE RESPIRATORY FAILURE 178 0.0092
142 ATRIOVENTRICULAR BLOCK FIRST DEGREE 40 0.0092
143 POSTOPERATIVE WOUND INFECTION 62 0.0092
144 HYPERLIPIDAEMIA 109 0.0091
145 RENAL TUBULAR NECROSIS 89 0.0091
146 DUODENAL ULCER 64 0.0091
147 RENAL INJURY 269 0.0090
148 MULTIPLE INJURIES 57 0.0090
149 SNORING 34 0.0090
150 OEDEMA 486 0.0090
151 AORTIC VALVE INCOMPETENCE 38 0.0089
152 PROSTATOMEGALY 35 0.0089
153 CARDIOMEGALY 109 0.0089
154 SLEEP APNOEA SYNDROME 168 0.0088
155 GLUCOSE TOLERANCE IMPAIRED 52 0.0088
156 HYPERTENSIVE CRISIS 97 0.0087
157 FURUNCLE 69 0.0087
158 BLOOD PRESSURE DIASTOLIC DECREASED 64 0.0087
159 VENTRICULAR EXTRASYSTOLES 90 0.0087
160 LOCALISED OEDEMA 40 0.0086
161 HEPATIC STEATOSIS 160 0.0086
162 RED BLOOD CELL SEDIMENTATION RATE INCREASED 95 0.0086
163 LACTIC ACIDOSIS 277 0.0085
164 GOITRE 35 0.0085
165 LOWER GASTROINTESTINAL HAEMORRHAGE 63 0.0085
166 BLOOD PRESSURE FLUCTUATION 204 0.0085
167 CARDIAC FAILURE 681 0.0085
168 ANGINA UNSTABLE 55 0.0085
169 HYPOCALCAEMIA 160 0.0084
170 ECONOMIC PROBLEM 128 0.0084
171 VASCULITIS 98 0.0084
172 SEASONAL ALLERGY 117 0.0083
173 RED CELL DISTRIBUTION WIDTH INCREASED 34 0.0082
174 ANURIA 70 0.0081
175 RENAL IMPAIRMENT 678 0.0081
176 HYPERURICAEMIA 33 0.0080
177 ATRIAL FLUTTER 64 0.0080
178 EXOSTOSIS 73 0.0080
179 BLOOD PRESSURE ABNORMAL 157 0.0079
180 CATHETERISATION CARDIAC 35 0.0079
181 DIABETIC NEUROPATHY 39 0.0079
182 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
183 OESOPHAGEAL CANDIDIASIS 31 0.0078
184 DRUG INTERACTION 1232 0.0078
185 SCOLIOSIS 48 0.0077
186 TRANSFUSION 81 0.0077
187 RHABDOMYOLYSIS 322 0.0077
188 HYPOTENSION 1544 0.0077
189 LEFT VENTRICULAR DYSFUNCTION 51 0.0076
190 UROSEPSIS 70 0.0076
191 BENIGN PROSTATIC HYPERPLASIA 39 0.0075
192 HEART RATE DECREASED 264 0.0075
193 GASTRITIS EROSIVE 35 0.0075
194 SYNCOPE 747 0.0075
195 EJECTION FRACTION DECREASED 116 0.0075
196 UPPER GASTROINTESTINAL HAEMORRHAGE 125 0.0074
197 BLOOD LACTIC ACID INCREASED 39 0.0074
198 DIVERTICULUM INTESTINAL 32 0.0073
199 DEHYDRATION 971 0.0073
200 CONGESTIVE CARDIOMYOPATHY 30 0.0072
201 MYOCARDIAL ISCHAEMIA 81 0.0071
202 SPRUE-LIKE ENTEROPATHY 35 0.0071
203 ELECTROCARDIOGRAM QT PROLONGED 253 0.0070
204 BLOOD CREATINE INCREASED 31 0.0070
205 WHEEZING 413 0.0070
206 EOSINOPHILIA 122 0.0070
207 PRODUCTIVE COUGH 329 0.0069
208 CELLULITIS 346 0.0069
209 BLADDER DISORDER 68 0.0068
210 NOCTURIA 83 0.0068
211 BLOOD PRESSURE INCREASED 1045 0.0068
212 VASCULAR DEVICE INFECTION 31 0.0068
213 DERMATITIS EXFOLIATIVE 34 0.0068
214 EAR DISORDER 31 0.0068
215 SPUTUM DISCOLOURED 64 0.0067
216 PERIORBITAL OEDEMA 35 0.0067
217 HYPOXIA 237 0.0067
218 HEART RATE IRREGULAR 152 0.0067
219 ATRIOVENTRICULAR BLOCK COMPLETE 45 0.0067
220 CARDIOMYOPATHY 99 0.0067
221 METABOLIC ACIDOSIS 214 0.0067
222 RENAL CYST 53 0.0067
223 HYPERCALCAEMIA 82 0.0066
224 PERIPHERAL COLDNESS 91 0.0066
225 HYPERNATRAEMIA 33 0.0066
226 GASTROINTESTINAL HAEMORRHAGE 553 0.0066
227 DIVERTICULUM 47 0.0066
228 BODY TEMPERATURE DECREASED 65 0.0066
229 SINUS CONGESTION 89 0.0066
230 PERIPHERAL SWELLING 1014 0.0066
231 TROPONIN INCREASED 50 0.0066
232 FRUSTRATION TOLERANCE DECREASED 53 0.0066
233 INTERNATIONAL NORMALISED RATIO INCREASED 187 0.0066
234 HAEMODIALYSIS 55 0.0065
235 STRESS CARDIOMYOPATHY 38 0.0065
236 SKIN LACERATION 71 0.0065
237 PULSE ABSENT 31 0.0065
238 PULMONARY OEDEMA 291 0.0065
239 LEUKOCYTOSIS 117 0.0065
240 HAEMATOCRIT DECREASED 128 0.0064
241 VARICOSE VEIN 33 0.0064
242 MYOPATHY 55 0.0064
243 BLOOD PRESSURE DECREASED 421 0.0063
244 HYPERCHOLESTEROLAEMIA 61 0.0063
245 GINGIVITIS 34 0.0063
246 VENTRICULAR FIBRILLATION 70 0.0063
247 HYPERTHYROIDISM 91 0.0063
248 BLOOD URINE PRESENT 119 0.0063
249 HAEMATOMA 162 0.0062
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 326 0.0062
251 ACUTE PULMONARY OEDEMA 35 0.0062
252 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 55 0.0062
253 SUSPECTED SUICIDE 29 0.0062
254 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 48 0.0062
255 CORONARY ARTERY STENOSIS 31 0.0062
256 HYPERKERATOSIS 34 0.0062
257 DIABETES MELLITUS INADEQUATE CONTROL 109 0.0062
258 MASS 86 0.0061
259 OXYGEN SATURATION DECREASED 344 0.0061
260 CORONARY ARTERY DISEASE 185 0.0061
261 SKIN ATROPHY 35 0.0061
262 LYMPHOEDEMA 42 0.0061
263 PULMONARY CONGESTION 80 0.0061
264 ARRHYTHMIA 284 0.0060
265 INCREASED TENDENCY TO BRUISE 55 0.0060
266 PERICARDIAL EFFUSION 138 0.0060
267 MYOCLONUS 71 0.0059
268 HAEMORRHOIDAL HAEMORRHAGE 29 0.0059
269 HYPERTENSION 1258 0.0059
270 SPINAL PAIN 69 0.0059
271 APPETITE DISORDER 39 0.0059
272 PRODUCT ADMINISTRATION INTERRUPTED 46 0.0059
273 CARDIOGENIC SHOCK 84 0.0058
274 OBSTRUCTIVE AIRWAYS DISORDER 65 0.0058
275 CONFUSIONAL STATE 943 0.0058
276 NEUTROPHILIA 33 0.0058
277 ACUTE MYOCARDIAL INFARCTION 171 0.0058
278 HAEMOGLOBIN DECREASED 595 0.0058
279 BRONCHIECTASIS 39 0.0058
280 CORONARY ARTERY OCCLUSION 79 0.0058
281 INGUINAL HERNIA 35 0.0057
282 HELICOBACTER INFECTION 59 0.0057
283 PAIN IN JAW 162 0.0057
284 OSTEOARTHRITIS 242 0.0057
285 POOR VENOUS ACCESS 59 0.0057
286 BLOOD CALCIUM INCREASED 50 0.0057
287 PROTHROMBIN TIME PROLONGED 34 0.0057
288 LOCALISED INFECTION 137 0.0057
289 ASCITES 166 0.0056
290 THYROID DISORDER 87 0.0056
291 URINARY INCONTINENCE 167 0.0056
292 ANGIOEDEMA 249 0.0056
293 INJECTION SITE DISCOMFORT 59 0.0056
294 HYPOTONIA 56 0.0056
295 MELAENA 123 0.0056
296 RENAL DISORDER 260 0.0056
297 HYPOGLYCAEMIA 270 0.0056
298 ECCHYMOSIS 38 0.0055
299 DYSURIA 204 0.0055
300 CARDIAC PACEMAKER INSERTION 33 0.0055
301 GASTRIC ULCER 105 0.0055
302 MUSCULOSKELETAL DISCOMFORT 95 0.0055
303 CIRCULATORY COLLAPSE 94 0.0055
304 RESPIRATORY DISTRESS 152 0.0055
305 HAEMORRHOIDS 107 0.0055
306 COLITIS ISCHAEMIC 37 0.0055
307 RASH MACULO-PAPULAR 122 0.0055
308 HIATUS HERNIA 71 0.0055
309 COAGULOPATHY 91 0.0055
310 RHINITIS 44 0.0055
311 ANGINA PECTORIS 156 0.0054
312 DIABETES MELLITUS 415 0.0054
313 LUNG INFILTRATION 48 0.0054
314 ACUTE CORONARY SYNDROME 45 0.0054
315 EPISTAXIS 406 0.0054
316 MOUTH ULCERATION 114 0.0054
317 ERECTILE DYSFUNCTION 138 0.0054
318 HYPOPHAGIA 136 0.0053
319 GANGRENE 32 0.0053
320 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 90 0.0053
321 C-REACTIVE PROTEIN INCREASED 192 0.0053
322 PROTEINURIA 100 0.0053
323 HYPERGLYCAEMIA 191 0.0052
324 PURPURA 46 0.0052
325 TYPE 2 DIABETES MELLITUS 175 0.0052
326 WRONG PRODUCT ADMINISTERED 35 0.0052
327 PEMPHIGOID 39 0.0052
328 LETHARGY 296 0.0051
329 GASTRITIS 135 0.0051
330 PLEURAL EFFUSION 312 0.0051
331 OESOPHAGITIS 56 0.0051
332 SUPRAVENTRICULAR TACHYCARDIA 49 0.0051
333 WOUND INFECTION 56 0.0051
334 WHITE BLOOD CELL COUNT INCREASED 196 0.0051
335 NEPHROTIC SYNDROME 35 0.0051
336 JOINT SWELLING 615 0.0051
337 STEVENS-JOHNSON SYNDROME 113 0.0051
338 PANCREATITIS ACUTE 114 0.0051
339 GLYCOSYLATED HAEMOGLOBIN INCREASED 128 0.0051
340 GASTROENTERITIS 74 0.0051
341 SKIN ULCER 131 0.0051
342 ORAL DISORDER 37 0.0050
343 SHOCK 116 0.0050
344 EXERCISE TOLERANCE DECREASED 29 0.0050
345 HEPATIC ENCEPHALOPATHY 47 0.0050
346 DYSPNOEA 2839 0.0050
347 RESTLESS LEGS SYNDROME 91 0.0050
348 DERMATITIS CONTACT 57 0.0050
349 HAEMATURIA 171 0.0050
350 GINGIVAL BLEEDING 68 0.0050
351 HAEMOGLOBIN ABNORMAL 32 0.0050
352 RECTAL HAEMORRHAGE 213 0.0050
353 FAECES SOFT 36 0.0049
354 ANAEMIA 943 0.0049
355 OSTEOPENIA 75 0.0049
356 MALNUTRITION 55 0.0049
357 FALL 1633 0.0049
358 PHARYNGEAL SWELLING 48 0.0049
359 INTERNAL HAEMORRHAGE 56 0.0049
360 COUGH 1370 0.0049
361 TOXIC EPIDERMAL NECROLYSIS 74 0.0049
362 SPLENOMEGALY 57 0.0049
363 DIALYSIS 69 0.0049
364 ACUTE RESPIRATORY DISTRESS SYNDROME 86 0.0049
365 TACHYPNOEA 66 0.0048
366 CHEST DISCOMFORT 497 0.0048
367 NASAL CONGESTION 285 0.0048
368 LIPASE INCREASED 37 0.0048
369 CHEST PAIN 890 0.0048
370 DISORIENTATION 190 0.0048
371 CHOLELITHIASIS 157 0.0048
372 CHOLECYSTITIS 57 0.0048
373 HEPATOMEGALY 47 0.0048
374 LOW DENSITY LIPOPROTEIN INCREASED 37 0.0048
375 POLLAKIURIA 199 0.0048
376 GALLBLADDER DISORDER 85 0.0048
377 BLOOD TRIGLYCERIDES INCREASED 84 0.0047
378 BLOOD IRON DECREASED 56 0.0047
379 RENAL PAIN 50 0.0047
380 ASTHENIA 1773 0.0047
381 DRUG LEVEL INCREASED 78 0.0047
382 SWELLING FACE 306 0.0047
383 WEIGHT FLUCTUATION 49 0.0047
384 VITAMIN D DECREASED 40 0.0047
385 LIMB INJURY 127 0.0047
386 SWOLLEN TONGUE 146 0.0047
387 EMPHYSEMA 47 0.0047
388 PRE-EXISTING CONDITION IMPROVED 29 0.0046
389 MUSCULAR WEAKNESS 527 0.0046
390 FEELING COLD 129 0.0046
391 PULMONARY MASS 69 0.0046
392 OROPHARYNGEAL PAIN 428 0.0046
393 RIB FRACTURE 95 0.0046
394 URINARY RETENTION 154 0.0046
395 CHOLESTASIS 88 0.0046
396 HEAD INJURY 145 0.0046
397 DIZZINESS 2283 0.0046
398 FULL BLOOD COUNT DECREASED 92 0.0046
399 HOSPICE CARE 45 0.0046
400 NERVE COMPRESSION 42 0.0045
401 WALKING AID USER 30 0.0045
402 HALLUCINATION, VISUAL 96 0.0045
403 GRIP STRENGTH DECREASED 40 0.0045
404 INCONTINENCE 48 0.0045
405 ERYTHEMA MULTIFORME 42 0.0045
406 JOINT EFFUSION 31 0.0045
407 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
408 LIP SWELLING 149 0.0045
409 ASPIRATION 49 0.0045
410 RETINAL DETACHMENT 41 0.0045
411 MUSCULOSKELETAL CHEST PAIN 69 0.0045
412 CARDIAC ARREST 368 0.0045
413 RESPIRATORY FAILURE 325 0.0045
414 URINARY TRACT INFECTION 759 0.0044
415 GASTROOESOPHAGEAL REFLUX DISEASE 358 0.0044
416 ORAL PAIN 99 0.0044
417 BLOOD ALBUMIN DECREASED 35 0.0044
418 SKIN LESION 120 0.0044
419 ISCHAEMIC STROKE 78 0.0044
420 TREATMENT NONCOMPLIANCE 239 0.0044
421 HAEMOLYTIC ANAEMIA 39 0.0043
422 UPPER RESPIRATORY TRACT INFECTION 201 0.0043
423 JAUNDICE 117 0.0043
424 MYALGIA 738 0.0043
425 ELECTROCARDIOGRAM ABNORMAL 34 0.0043
426 HAEMODYNAMIC INSTABILITY 33 0.0043
427 WOUND 121 0.0043
428 CONTRAINDICATED PRODUCT ADMINISTERED 131 0.0043
429 DELIRIUM 150 0.0043
430 MENTAL STATUS CHANGES 120 0.0043
431 EATING DISORDER 92 0.0043
432 VITAMIN D DEFICIENCY 42 0.0043
433 NEUROLEPTIC MALIGNANT SYNDROME 51 0.0043
434 BLOOD COUNT ABNORMAL 65 0.0043
435 HEPATIC CIRRHOSIS 80 0.0043
436 IMPAIRED GASTRIC EMPTYING 58 0.0043
437 ABNORMAL LOSS OF WEIGHT 29 0.0042
438 INFLUENZA 474 0.0042
439 HYPOALBUMINAEMIA 33 0.0042
440 SEPTIC SHOCK 184 0.0042
441 HYPOTHYROIDISM 135 0.0042
442 ANHEDONIA 111 0.0042
443 RESPIRATORY TRACT INFECTION 110 0.0042
444 NECK PAIN 236 0.0042
445 MULTI-ORGAN FAILURE 73 0.0042
446 DIVERTICULITIS 117 0.0042
447 INTERVERTEBRAL DISC DEGENERATION 39 0.0042
448 TENDONITIS 65 0.0042
449 THIRST 75 0.0042
450 ARTHRITIS 330 0.0042
451 WEIGHT DECREASED 1171 0.0042
452 POST PROCEDURAL INFECTION 34 0.0042
453 DECREASED ACTIVITY 45 0.0042
454 CLOSTRIDIUM DIFFICILE INFECTION 91 0.0042
455 EYE INFECTION 47 0.0042
456 CONTUSION 399 0.0041
457 SINUS DISORDER 82 0.0041
458 HYPOKINESIA 60 0.0041
459 RED BLOOD CELL COUNT DECREASED 118 0.0041
460 THROAT IRRITATION 185 0.0041
461 BURSITIS 50 0.0041
462 SPINAL DISORDER 39 0.0041
463 BONE DISORDER 75 0.0041
464 BODY HEIGHT DECREASED 44 0.0041
465 MOBILITY DECREASED 295 0.0041
466 SENSORY LOSS 33 0.0041
467 GROIN PAIN 36 0.0041
468 EAR DISCOMFORT 42 0.0041
469 BLOOD CALCIUM DECREASED 46 0.0041
470 LOWER RESPIRATORY TRACT INFECTION 186 0.0041
471 LUNG DISORDER 200 0.0041
472 SECRETION DISCHARGE 51 0.0041
473 LIMB DISCOMFORT 126 0.0041
474 PROSTATIC SPECIFIC ANTIGEN INCREASED 56 0.0041
475 NODULE 53 0.0041
476 FAECES DISCOLOURED 88 0.0041
477 LOSS OF CONSCIOUSNESS 520 0.0041
478 BOWEL MOVEMENT IRREGULARITY 31 0.0040
479 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 194 0.0040
480 DRY THROAT 41 0.0040
481 BLOOD CREATINE PHOSPHOKINASE INCREASED 116 0.0040
482 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
483 SLUGGISHNESS 41 0.0040
484 CARPAL TUNNEL SYNDROME 56 0.0040
485 CONSTIPATION 872 0.0040
486 DECREASED APPETITE 927 0.0040
487 DYSARTHRIA 150 0.0040
488 HAEMORRHAGIC STROKE 31 0.0040
489 MYASTHENIA GRAVIS 32 0.0040
490 GAIT DISTURBANCE 758 0.0040
491 RESPIRATORY RATE INCREASED 35 0.0039
492 ALANINE AMINOTRANSFERASE INCREASED 242 0.0039
493 SUBARACHNOID HAEMORRHAGE 40 0.0039
494 BLOOD GLUCOSE FLUCTUATION 43 0.0039
495 TRANSIENT ISCHAEMIC ATTACK 132 0.0039
496 WEIGHT INCREASED 876 0.0039
497 RESPIRATORY TRACT CONGESTION 62 0.0039
498 ULCER 62 0.0039
499 HAEMATOCHEZIA 215 0.0039
500 SCIATICA 62 0.0039
501 PNEUMONIA 1257 0.0039
502 KETOACIDOSIS 29 0.0039
503 ASTHMA 438 0.0039
504 MUSCULOSKELETAL PAIN 203 0.0039
505 BLOOD GLUCOSE DECREASED 186 0.0039
506 SINUS TACHYCARDIA 55 0.0039
507 OSTEOMYELITIS 70 0.0039
508 PALLOR 105 0.0039
509 MICTURITION URGENCY 44 0.0038
510 MACULAR DEGENERATION 46 0.0038
511 SWELLING 359 0.0038
512 HAEMATEMESIS 97 0.0038
513 PALPITATIONS 448 0.0038
514 BRONCHITIS 283 0.0038
515 ASPARTATE AMINOTRANSFERASE INCREASED 203 0.0038
516 DECUBITUS ULCER 31 0.0038
517 PARKINSONISM 37 0.0038
518 NEPHROLITHIASIS 174 0.0038
519 BACTERAEMIA 45 0.0038
520 BACK PAIN 880 0.0038
521 PAIN IN EXTREMITY 1116 0.0038
522 HEAD DISCOMFORT 67 0.0038
523 BASAL CELL CARCINOMA 59 0.0038
524 HICCUPS 31 0.0038
525 SCAB 43 0.0038
526 UNRESPONSIVE TO STIMULI 97 0.0038
527 DRY MOUTH 304 0.0037
528 ABDOMINAL DISTENSION 391 0.0037
529 SEPSIS 417 0.0037
530 DEPRESSED MOOD 197 0.0037
531 PRODUCT ODOUR ABNORMAL 39 0.0037
532 MUSCLE SPASMS 683 0.0037
533 DIARRHOEA 2398 0.0037
534 DRUG INTOLERANCE 358 0.0037
535 MUSCLE TIGHTNESS 60 0.0037
536 PYELONEPHRITIS 32 0.0037
537 FOOT FRACTURE 70 0.0037
538 BLISTER 207 0.0037
539 POOR QUALITY SLEEP 79 0.0037
540 LIVER FUNCTION TEST ABNORMAL 106 0.0036
541 CATARACT 217 0.0036
542 SPINAL FRACTURE 73 0.0036
543 SUBDURAL HAEMATOMA 52 0.0036
544 DYSPHONIA 212 0.0036
545 RESPIRATORY DISORDER 108 0.0036
546 SEROTONIN SYNDROME 69 0.0036
547 BLOOD BILIRUBIN INCREASED 97 0.0036
548 TOOTHACHE 65 0.0036
549 ABDOMINAL PAIN 835 0.0036
550 HAEMOPTYSIS 100 0.0036
551 JOINT STIFFNESS 94 0.0036
552 COLD SWEAT 63 0.0036
553 MUSCLE ATROPHY 45 0.0035
554 PULMONARY FIBROSIS 68 0.0035
555 CARDIO-RESPIRATORY ARREST 147 0.0035
556 JOINT INJURY 75 0.0035
557 MEDICATION ERROR 195 0.0035
558 DEVICE RELATED INFECTION 54 0.0035
559 JOINT RANGE OF MOTION DECREASED 47 0.0035
560 BRONCHOSPASM 50 0.0035
561 HYPERSOMNIA 100 0.0035
562 MALAISE 1528 0.0035
563 IMPAIRED QUALITY OF LIFE 50 0.0035
564 ARTHRALGIA 1446 0.0035
565 PRURITUS GENERALISED 75 0.0035
566 MUSCLE STRAIN 30 0.0035
567 BONE PAIN 203 0.0035
568 SYSTEMIC LUPUS ERYTHEMATOSUS 123 0.0035
569 CHROMATURIA 78 0.0035
570 NEURALGIA 84 0.0035
571 CONDITION AGGRAVATED 1050 0.0034
572 NAIL DISORDER 30 0.0034
573 INTENTIONAL PRODUCT USE ISSUE 300 0.0034
574 ANKLE FRACTURE 53 0.0034
575 HYPERHIDROSIS 441 0.0034
576 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 88 0.0034
577 BALANCE DISORDER 295 0.0034
578 CARDIAC DISORDER 317 0.0034
579 SKIN INFECTION 38 0.0034
580 PSYCHOTIC DISORDER 100 0.0034
581 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
582 RETCHING 72 0.0034
583 RHINORRHOEA 218 0.0034
584 TENDERNESS 35 0.0034
585 PETECHIAE 35 0.0034
586 VOMITING 1576 0.0033
587 SKIN DISCOLOURATION 154 0.0033
588 FLATULENCE 190 0.0033
589 ROTATOR CUFF SYNDROME 43 0.0033
590 BLOOD GLUCOSE INCREASED 629 0.0033
591 ANOREXIA 43 0.0033
592 ANAL INCONTINENCE 30 0.0033
593 HEART RATE INCREASED 330 0.0033
594 RESPIRATORY SYNCYTIAL VIRUS INFECTION 29 0.0033
595 DRUG ERUPTION 59 0.0033
596 CYSTITIS 106 0.0033
597 LABORATORY TEST ABNORMAL 98 0.0033
598 BACK INJURY 36 0.0033
599 STAPHYLOCOCCAL INFECTION 109 0.0033
600 HOT FLUSH 249 0.0033
601 BLOOD CHOLESTEROL INCREASED 154 0.0033
602 FEEDING DISORDER 67 0.0033
603 PLATELET COUNT INCREASED 43 0.0033
604 VERTIGO 201 0.0033
605 EAR PAIN 64 0.0033
606 TINNITUS 151 0.0033
607 NEUROPATHY PERIPHERAL 312 0.0033
608 GLAUCOMA 63 0.0033
609 DYSPHAGIA 310 0.0033
610 FATIGUE 2541 0.0033
611 NAUSEA 2576 0.0033
612 WRIST FRACTURE 39 0.0033
613 POST PROCEDURAL COMPLICATION 62 0.0032
614 ABDOMINAL PAIN UPPER 664 0.0032
615 SOMNOLENCE 649 0.0032
616 SCRATCH 34 0.0032
617 JOINT DISLOCATION 34 0.0032
618 SUDDEN DEATH 34 0.0032
619 GASTROENTERITIS VIRAL 58 0.0032
620 RASH PAPULAR 72 0.0032
621 GENERAL PHYSICAL HEALTH DETERIORATION 371 0.0032
622 INTERVERTEBRAL DISC PROTRUSION 70 0.0032
623 FLANK PAIN 30 0.0032
624 SINUSITIS 328 0.0032
625 IMPAIRED HEALING 105 0.0032
626 DISEASE RECURRENCE 152 0.0032
627 BLOOD GLUCOSE ABNORMAL 59 0.0032
628 FLUSHING 322 0.0032
629 PULMONARY EMBOLISM 301 0.0032
630 NIGHT SWEATS 102 0.0032
631 ABDOMINAL DISCOMFORT 530 0.0032
632 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
633 LOCAL SWELLING 55 0.0031
634 PRODUCT PRESCRIBING ERROR 75 0.0031
635 DEEP VEIN THROMBOSIS 204 0.0031
636 BACK DISORDER 51 0.0031
637 KNEE ARTHROPLASTY 66 0.0031
638 HEADACHE 1962 0.0031
639 BRAIN FOG 49 0.0031
640 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
641 TOOTH INFECTION 41 0.0031
642 KIDNEY INFECTION 61 0.0031
643 ERUCTATION 60 0.0031
644 SALIVARY HYPERSECRETION 31 0.0031
645 SMALL INTESTINAL OBSTRUCTION 38 0.0031
646 TOXIC SKIN ERUPTION 31 0.0031
647 LIVER FUNCTION TEST INCREASED 66 0.0031
648 LOWER LIMB FRACTURE 59 0.0031
649 DYSPEPSIA 300 0.0030
650 CEREBRAL HAEMORRHAGE 109 0.0030
651 TOOTH ABSCESS 31 0.0030
652 EAR INFECTION 81 0.0030
653 ARTHROPATHY 168 0.0030
654 VISION BLURRED 414 0.0030
655 MUSCULOSKELETAL STIFFNESS 264 0.0030
656 EYE PAIN 170 0.0030
657 POLYNEUROPATHY 36 0.0030
658 NASOPHARYNGITIS 554 0.0030
659 SPINAL OPERATION 37 0.0030
660 BREAST PAIN 32 0.0030
661 HERNIA 58 0.0030
662 TOOTH FRACTURE 33 0.0030
663 INTESTINAL OBSTRUCTION 112 0.0030
664 FACE OEDEMA 50 0.0030
665 ORAL CANDIDIASIS 39 0.0030
666 NEEDLE ISSUE 86 0.0030
667 RASH PRURITIC 160 0.0029
668 RASH ERYTHEMATOUS 141 0.0029
669 GASTROINTESTINAL DISORDER 264 0.0029
670 INTENTIONAL DOSE OMISSION 84 0.0029
671 OSTEOPOROSIS 121 0.0029
672 MUCOSAL INFLAMMATION 77 0.0029
673 APHONIA 41 0.0029
674 FEELING HOT 180 0.0029
675 NEUTROPHIL COUNT INCREASED 30 0.0029
676 SCAR 50 0.0029
677 DEVICE OCCLUSION 41 0.0029
678 SKIN DISORDER 97 0.0029
679 CANDIDA INFECTION 49 0.0029
680 SKIN HAEMORRHAGE 43 0.0029
681 FEAR 78 0.0029
682 TREMOR 481 0.0029
683 ILLNESS 298 0.0029
684 DEPRESSED LEVEL OF CONSCIOUSNESS 114 0.0029
685 SARS-COV-2 TEST POSITIVE 38 0.0029
686 GASTRIC HAEMORRHAGE 33 0.0029
687 TACHYCARDIA 254 0.0029
688 CONJUNCTIVITIS 53 0.0029
689 SLEEP DISORDER 201 0.0028
690 THROAT TIGHTNESS 77 0.0028
691 THROMBOCYTOPENIA 318 0.0028
692 PNEUMONIA ASPIRATION 71 0.0028
693 RESTLESSNESS 104 0.0028
694 PNEUMOTHORAX 45 0.0028
695 DRUG-INDUCED LIVER INJURY 89 0.0028
696 INSOMNIA 755 0.0028
697 HAIR COLOUR CHANGES 35 0.0028
698 UPPER LIMB FRACTURE 56 0.0028
699 TASTE DISORDER 57 0.0028
700 FEELING ABNORMAL 673 0.0028
701 HUNGER 39 0.0028
702 CHILLS 327 0.0028
703 DIABETIC KETOACIDOSIS 67 0.0028
704 CEREBROVASCULAR ACCIDENT 472 0.0028
705 HYPOAESTHESIA 417 0.0028
706 ACUTE HEPATIC FAILURE 38 0.0028
707 PARAESTHESIA 437 0.0028
708 HEPATITIS 71 0.0028
709 LIVER DISORDER 123 0.0028
710 COLITIS 105 0.0028
711 OCULAR DISCOMFORT 31 0.0028
712 VISUAL IMPAIRMENT 342 0.0028
713 COVID-19 482 0.0027
714 CYST 34 0.0027
715 HAEMORRHAGE 286 0.0027
716 PAIN 1674 0.0027
717 PHOTOSENSITIVITY REACTION 45 0.0027
718 COORDINATION ABNORMAL 38 0.0027
719 SEDATION 71 0.0027
720 HEREDITARY ANGIOEDEMA 29 0.0027
721 BURNING SENSATION 189 0.0027
722 MYOCARDIAL INFARCTION 468 0.0027
723 NEPHROPATHY TOXIC 30 0.0027
724 DYSSTASIA 78 0.0027
725 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
726 NIGHTMARE 92 0.0027
727 STOMATITIS 161 0.0027
728 TRANSAMINASES INCREASED 59 0.0027
729 PYREXIA 918 0.0027
730 ENCEPHALOPATHY 65 0.0026
731 ADRENAL INSUFFICIENCY 32 0.0026
732 RASH GENERALISED 68 0.0026
733 ANXIETY 747 0.0026
734 EYE HAEMORRHAGE 35 0.0026
735 COMPLICATION ASSOCIATED WITH DEVICE 38 0.0026
736 APHASIA 79 0.0026
737 RASH 1139 0.0026
738 MALIGNANT MELANOMA 35 0.0026
739 HIP ARTHROPLASTY 40 0.0026
740 AGEUSIA 65 0.0026
741 HEPATOTOXICITY 58 0.0026
742 HEPATIC ENZYME INCREASED 177 0.0026
743 HALLUCINATION 195 0.0026
744 BEDRIDDEN 34 0.0026
745 SNEEZING 58 0.0026
746 GAIT INABILITY 86 0.0026
747 AMNESIA 167 0.0026
748 SKIN FISSURES 50 0.0026
749 PRURITUS 983 0.0026
750 NO THERAPEUTIC RESPONSE 31 0.0025
751 HEPATOCELLULAR INJURY 36 0.0025
752 HEMIPARESIS 43 0.0025
753 PRODUCT PRESCRIBING ISSUE 55 0.0025
754 SKIN EXFOLIATION 213 0.0025
755 INCREASED APPETITE 48 0.0025
756 THROMBOSIS 202 0.0025
757 INTERSTITIAL LUNG DISEASE 121 0.0025
758 PARAESTHESIA ORAL 36 0.0025
759 BLOOD TEST ABNORMAL 35 0.0025
760 ROAD TRAFFIC ACCIDENT 104 0.0025
761 SPEECH DISORDER 130 0.0025
762 PANCREATITIS 131 0.0025
763 DYSGEUSIA 184 0.0025
764 UNEVALUABLE EVENT 187 0.0025
765 HERPES ZOSTER 141 0.0025
766 DRY EYE 122 0.0024
767 ATAXIA 29 0.0024
768 HYPERSENSITIVITY 453 0.0024
769 SKIN REACTION 34 0.0024
770 INJECTION SITE MASS 89 0.0024
771 PRODUCT DOSE OMISSION 157 0.0024
772 VIRAL INFECTION 80 0.0024
773 ALTERED STATE OF CONSCIOUSNESS 52 0.0024
774 APATHY 35 0.0024
775 PNEUMONITIS 65 0.0024
776 LACRIMATION INCREASED 72 0.0024
777 MEMORY IMPAIRMENT 327 0.0024
778 ORAL DISCOMFORT 33 0.0024
779 THERAPEUTIC PRODUCT EFFECT DECREASED 106 0.0024
780 PRODUCT TASTE ABNORMAL 32 0.0024
781 MUSCLE SPASTICITY 29 0.0024
782 THERAPY NON-RESPONDER 106 0.0024
783 HOSPITALISATION 361 0.0023
784 DRUG TOXICITY 32 0.0023
785 TOXICITY TO VARIOUS AGENTS 395 0.0023
786 HIP FRACTURE 75 0.0023
787 MUSCULOSKELETAL DISORDER 44 0.0023
788 QUALITY OF LIFE DECREASED 31 0.0023
789 DEPRESSION 525 0.0023
790 HYPOACUSIS 99 0.0023
791 DEAFNESS 60 0.0023
792 INSURANCE ISSUE 35 0.0023
793 ANAPHYLACTIC REACTION 126 0.0023
794 THERAPY CESSATION 117 0.0023
795 SKIN CANCER 49 0.0023
796 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 53 0.0023
797 GASTRIC DISORDER 78 0.0023
798 BLINDNESS UNILATERAL 32 0.0023
799 EYE SWELLING 84 0.0023
800 INFLUENZA LIKE ILLNESS 185 0.0022
801 MOVEMENT DISORDER 72 0.0022
802 RASH MACULAR 78 0.0022
803 FIBROMYALGIA 54 0.0022
804 AGITATION 163 0.0022
805 PANCYTOPENIA 124 0.0022
806 SEIZURE 256 0.0022
807 PHARYNGEAL OEDEMA 34 0.0022
808 INFLAMMATION 114 0.0022
809 PLATELET COUNT DECREASED 235 0.0022
810 VISUAL ACUITY REDUCED 73 0.0022
811 MIDDLE INSOMNIA 41 0.0022
812 GLOSSODYNIA 49 0.0022
813 INFUSION RELATED REACTION 145 0.0022
814 COGNITIVE DISORDER 102 0.0022
815 THERAPY INTERRUPTED 156 0.0022
816 ACTIVITIES OF DAILY LIVING IMPAIRED 43 0.0022
817 MUSCLE TWITCHING 50 0.0022
818 PRODUCT DISPENSING ERROR 47 0.0022
819 ILL-DEFINED DISORDER 131 0.0022
820 CHOKING 42 0.0022
821 ORAL HERPES 42 0.0021
822 INJURY 151 0.0021
823 BACTERIAL INFECTION 40 0.0021
824 COMA 102 0.0021
825 ERYTHEMA 440 0.0021
826 INFECTION 309 0.0021
827 HYPOAESTHESIA ORAL 32 0.0021
828 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 151 0.0021
829 LUNG NEOPLASM MALIGNANT 87 0.0021
830 DEMENTIA 59 0.0021
831 FUNGAL INFECTION 70 0.0021
832 COLON CANCER 31 0.0021
833 PRODUCT ADMINISTRATION ERROR 42 0.0021
834 WHITE BLOOD CELL COUNT DECREASED 225 0.0021
835 PSORIATIC ARTHROPATHY 84 0.0021
836 FRACTURE 39 0.0021
837 DISTURBANCE IN ATTENTION 111 0.0021
838 CEREBRAL INFARCTION 50 0.0020
839 URTICARIA 342 0.0020
840 DIPLOPIA 53 0.0020
841 FREQUENT BOWEL MOVEMENTS 55 0.0020
842 PRODUCT USE COMPLAINT 32 0.0020
843 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
844 DYSKINESIA 82 0.0020
845 ABDOMINAL PAIN LOWER 51 0.0020
846 ANAPHYLACTIC SHOCK 52 0.0020
847 DISCOMFORT 121 0.0020
848 LYMPHADENOPATHY 70 0.0020
849 MENTAL DISORDER 86 0.0020
850 NERVOUSNESS 103 0.0020
851 DISEASE PROGRESSION 233 0.0020
852 PHOTOPHOBIA 37 0.0020
853 DRUG DISPENSING ERROR 30 0.0020
854 PRESCRIBED UNDERDOSE 39 0.0020
855 METASTASES TO BONE 32 0.0019
856 MULTIPLE FRACTURES 32 0.0019
857 DRUG RESISTANCE 50 0.0019
858 SURGERY 114 0.0019
859 ABASIA 48 0.0019
860 FEMUR FRACTURE 60 0.0019
861 AGRANULOCYTOSIS 36 0.0019
862 LUNG INFECTION 30 0.0019
863 ECZEMA 101 0.0019
864 PRODUCT USE ISSUE 362 0.0019
865 IRRITABLE BOWEL SYNDROME 41 0.0019
866 BODY TEMPERATURE INCREASED 39 0.0019
867 UNDERDOSE 138 0.0019
868 NEUTROPENIA 254 0.0019
869 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
870 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 336 0.0019
871 MENTAL IMPAIRMENT 45 0.0019
872 ABNORMAL DREAMS 51 0.0018
873 OFF LABEL USE 1617 0.0018
874 EYE PRURITUS 62 0.0018
875 THINKING ABNORMAL 34 0.0018
876 CARDIOVASCULAR DISORDER 46 0.0018
877 NEOPLASM PROGRESSION 63 0.0018
878 ALOPECIA 355 0.0018
879 SENSORY DISTURBANCE 29 0.0018
880 TOOTH DISORDER 40 0.0018
881 RHEUMATOID ARTHRITIS 204 0.0018
882 PRODUCT DOSE OMISSION ISSUE 527 0.0018
883 FEELING JITTERY 34 0.0018
884 MIGRAINE 170 0.0018
885 EYE IRRITATION 102 0.0018
886 PRODUCT SUBSTITUTION ISSUE 102 0.0018
887 DISABILITY 35 0.0018
888 EYE DISORDER 58 0.0018
889 METASTASES TO LIVER 31 0.0018
890 MOOD ALTERED 48 0.0018
891 BONE DENSITY DECREASED 55 0.0018
892 LYMPHOCYTE COUNT DECREASED 31 0.0018
893 INTENTIONAL PRODUCT MISUSE 151 0.0017
894 INCORRECT PRODUCT ADMINISTRATION DURATION 37 0.0017
895 PANIC ATTACK 62 0.0017
896 PROCEDURAL PAIN 47 0.0017
897 HEPATIC FAILURE 51 0.0017
898 EMOTIONAL DISORDER 52 0.0017
899 THERAPEUTIC RESPONSE DECREASED 102 0.0017
900 DERMATITIS 35 0.0017
901 LIVER INJURY 41 0.0017
902 WITHDRAWAL SYNDROME 70 0.0017
903 PRODUCT DOSE OMISSION IN ERROR 47 0.0017
904 COLITIS ULCERATIVE 74 0.0017
905 DEATH 1416 0.0016
906 OCULAR HYPERAEMIA 78 0.0016
907 PRODUCT USE IN UNAPPROVED INDICATION 406 0.0016
908 THERAPEUTIC RESPONSE SHORTENED 54 0.0016
909 COMPLETED SUICIDE 135 0.0016
910 EXTRAPYRAMIDAL DISORDER 40 0.0016
911 THERAPEUTIC RESPONSE UNEXPECTED 72 0.0016
912 PSORIASIS 209 0.0016
913 RESPIRATORY ARREST 44 0.0016
914 CONVULSION 89 0.0016
915 INJECTION SITE BRUISING 124 0.0016
916 DRY SKIN 207 0.0015
917 EPILEPSY 47 0.0015
918 MOOD SWINGS 49 0.0015
919 HEPATIC FUNCTION ABNORMAL 57 0.0015
920 PAIN OF SKIN 41 0.0015
921 BLINDNESS 62 0.0015
922 DRUG PRESCRIBING ERROR 29 0.0015
923 PRESCRIBED OVERDOSE 29 0.0015
924 IMPAIRED WORK ABILITY 32 0.0015
925 DRUG INEFFECTIVE 1968 0.0015
926 MALIGNANT NEOPLASM PROGRESSION 151 0.0015
927 PERITONITIS 30 0.0014
928 DEVICE DISLOCATION 62 0.0014
929 ADVERSE DRUG REACTION 128 0.0014
930 EMOTIONAL DISTRESS 171 0.0014
931 NERVOUS SYSTEM DISORDER 44 0.0014
932 INCORRECT DOSE ADMINISTERED 317 0.0014
933 DEVICE LEAKAGE 60 0.0014
934 DEVICE MALFUNCTION 97 0.0014
935 ACCIDENTAL OVERDOSE 50 0.0014
936 GYNAECOMASTIA 42 0.0014
937 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 96 0.0013
938 TARDIVE DYSKINESIA 38 0.0013
939 LEUKOPENIA 67 0.0013
940 PLASMA CELL MYELOMA 52 0.0013
941 DRUG DOSE OMISSION 220 0.0013
942 NEUTROPHIL COUNT DECREASED 54 0.0013
943 DRUG EFFECT INCOMPLETE 48 0.0013
944 FEBRILE NEUTROPENIA 87 0.0013
945 INTENTIONAL OVERDOSE 84 0.0013
946 PHARMACEUTICAL PRODUCT COMPLAINT 34 0.0013
947 DRUG ADMINISTRATION ERROR 40 0.0013
948 NEOPLASM MALIGNANT 86 0.0013
949 INJECTION SITE PRURITUS 86 0.0013
950 PRODUCT AVAILABILITY ISSUE 29 0.0013
951 DRUG EFFECT DECREASED 67 0.0012
952 EXPIRED PRODUCT ADMINISTERED 41 0.0012
953 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
954 OSTEONECROSIS OF JAW 30 0.0012
955 IRRITABILITY 72 0.0012
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 241 0.0012
957 ABNORMAL BEHAVIOUR 47 0.0012
958 SUICIDE ATTEMPT 71 0.0012
959 PRODUCT QUALITY ISSUE 158 0.0012
960 EXPOSURE VIA SKIN CONTACT 30 0.0012
961 INJECTION SITE HAEMORRHAGE 92 0.0012
962 CRYING 41 0.0011
963 DEVICE ISSUE 99 0.0011
964 INJECTION SITE PAIN 337 0.0011
965 MULTIPLE SCLEROSIS 52 0.0011
966 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39 0.0011
967 ANGER 36 0.0011
968 ADVERSE EVENT 98 0.0011
969 SUICIDAL IDEATION 97 0.0011
970 SKIN IRRITATION 48 0.0010
971 OVERDOSE 225 0.0010
972 SKIN BURNING SENSATION 72 0.0010
973 EXTRA DOSE ADMINISTERED 40 0.0010
974 AGGRESSION 49 0.0010
975 INJECTION SITE ERYTHEMA 120 0.0010
976 BREAST CANCER 90 0.0010
977 DEVICE USE ERROR 32 0.0009
978 ACNE 68 0.0009
979 DEVICE BREAKAGE 35 0.0009
980 DERMATITIS ATOPIC 45 0.0009
981 PROSTATE CANCER 67 0.0008
982 VAGINAL HAEMORRHAGE 36 0.0008
983 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
984 INJECTION SITE REACTION 55 0.0008
985 INJECTION SITE SWELLING 59 0.0008
986 TREATMENT FAILURE 57 0.0007
987 PRODUCT STORAGE ERROR 52 0.0006
988 ACCIDENTAL EXPOSURE TO PRODUCT 61 0.0006
989 FOETAL EXPOSURE DURING PREGNANCY 48 0.0006
990 DEVICE DIFFICULT TO USE 39 0.0006
991 NO ADVERSE EVENT 83 0.0005
992 DRUG DOSE OMISSION BY DEVICE 33 0.0004
993 DRUG DEPENDENCE 39 0.0002